Litcius/Paper detail

Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation

Timo Burster, Zhadyra Mustafa, Dinara Myrzakhmetova, Anuar Zhanapiya, Michał Zimecki

2021Frontiers in Chemistry23 citationsDOIOpen Access PDF

Abstract

During inflammation neutrophils become activated and segregate neutrophil serine proteases (NSPs) to the surrounding environment in order to support a natural immune defense. However, an excess of proteolytic activity of NSPs can cause many complications, such as cardiovascular diseases and chronic inflammatory disorders, which will be elucidated on a biochemical and immunological level. The application of selective serine protease inhibitors is the logical consequence in the management of the indicated comorbidities and will be summarized in this briefing.

Topics & Concepts

ProteasesSerine proteaseSerineInflammationProteaseProteolytic enzymesImmunologyChemistryBiochemistryMedicineEnzymeS100 Proteins and AnnexinsProtease and Inhibitor MechanismsNeutrophil, Myeloperoxidase and Oxidative Mechanisms
Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation | Litcius